SCHEMBL29958565

SCHEMBL29958565

NC(=O)Cn1ccc2ccc(Cl)cc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 3/20 0.61
KMT2A Q03164 2/20 0.47
OXER1 Q8TDS5 1/20 0.47
NPY5R Q15761 1/20 0.44
HTR7 P34969 2/20 0.44
LMNA P02545 1/20 0.43
ACLY P53396 1/20 0.43
MCL1 Q07820 1/20 0.42
RHEB Q15382 1/20 0.42
PRMT5 O14744 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
KRAS P01116 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.39
APOBEC3A P31941 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2006476 1.00 KMO (0.61) KMOKMT2AOXER1NPY5RHTR7
SCHEMBL29174329 0.94 KMO (0.63) KMOKMT2AOXER1NPY5RHTR7
SCHEMBL2006946 0.87 HTR2A (0.55) KMOKMT2AOXER1NPY5RLMNA
SCHEMBL1576364 0.85 KMO (0.72) KMOKMT2AOXER1NPY5RHTR7
SCHEMBL29957878 0.85 KMO (0.72) KMOKMT2AOXER1NPY5RHTR7
SCHEMBL3353214 0.82 LMNA (0.44) KMOKMT2ALMNAHTR2AHTR2C
SCHEMBL10203771 0.81 KMO (0.58) KMOKMT2AOXER1NPY5RHTR7
SCHEMBL31177216 0.81 HTR2C (0.55) KMOKMT2ANPY5RHTR7LMNA
SCHEMBL10165545 0.80 KMO (0.57) KMOKMT2AOXER1NPY5RHTR7
SCHEMBL24414633 0.79 LMNA (0.42) KMOKMT2ALMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308228-A1 PLASMA KALLIKREIN INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2024-01-24 EP disclosed
CN-117396474-A Plasma kallikrein inhibitors 武田药品工业株式会社 2024-01-12 CN disclosed
WO-2022197756-A1 PLASMA KALLIKREIN INHIBITORS SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 WO disclosed